These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7262640)

  • 1. Termination of pregnancy in a woman with hereditary antithrombin deficiency under antithrombotic protection with subcutaneous heparin and infusion of plasma.
    Jespersen J
    Gynecol Obstet Invest; 1981; 12(5):267-71. PubMed ID: 7262640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations during the treatment of antithrombin-III deficient women with heparin and antithrombin concentrate during pregnancy, parturition, and abortion.
    Brandt P
    Thromb Res; 1981 Apr 1-15; 22(1-2):15-24. PubMed ID: 7292437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis prophylaxis in pregnancy with use of subcutaneous heparin adjusted by monitoring heparin concentration in plasma.
    Dahlman TC; Hellgren MS; Blombäck M
    Am J Obstet Gynecol; 1989 Aug; 161(2):420-5. PubMed ID: 2764060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis of thrombosis in antithrombin III-deficient women during pregnancy and delivery.
    Michiels JJ; Stibbe J; Vellenga E; van Vliet HH
    Eur J Obstet Gynecol Reprod Biol; 1984 Oct; 18(3):149-53. PubMed ID: 6500155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous variant of antithrombin with lack of affinity for heparin: management of severe thrombotic complications associated with intrauterine fetal demise.
    Bauters A; Zawadzki C; Bura A; Théry C; Watel A; Subtil D; Aiach M; Emmerich J; Jude B
    Blood Coagul Fibrinolysis; 1996 Oct; 7(7):705-10. PubMed ID: 8958394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of pregnancy in women with antithrombin III congenital defect: report of four cases.
    De Stefano V; Leone G; De Carolis S; Ferrelli R; Di Donfrancesco A; Moneta E; Bizzi B
    Thromb Haemost; 1988 Apr; 59(2):193-6. PubMed ID: 3164529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency].
    Higuchi M; Konya H; Tanaka H; Masuda H; Nishida Y; Koyama T; Suehiro A; Kakishita E; Ishita K
    Rinsho Ketsueki; 1990 Sep; 31(9):1544-7. PubMed ID: 2246830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic and therapeutic use of anticoagulants in inherited antithrombin III deficiency.
    Zucker ML; Gomperts ED; Marcus RG
    S Afr Med J; 1976 Oct; 50(43):1743-8. PubMed ID: 63150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous heparin for thrombosis in pregnant women with hereditary antithrombin deficiency.
    Brandt P; Stenbjerg S
    Lancet; 1979 Jan; 1(8107):100-1. PubMed ID: 84100
    [No Abstract]   [Full Text] [Related]  

  • 11. Protection against venous thrombosis in an antithrombin-III deficient patient suffering from episodes of arterial thrombosis requiring major surgery. Effects of oral stanozolol in combination with subcutaneous heparin and intravenous AT-III.
    Jespersen J; Gram J; Kluft C; Astrup T
    Am J Clin Pathol; 1985 Jun; 83(6):768-71. PubMed ID: 4003344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary Antithrombin Deficiency Presenting with Deep Venous Thrombosis During the Second Pregnancy.
    Yamashita M; Komaki T; Tashiro K; Inada Y; Iwata A; Ogawa M; Morishita E; Miura SI
    Intern Med; 2020 Jan; 59(2):235-239. PubMed ID: 31554754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of thromboembolism during pregnancy in 3 sisters with congenital antithrombin III deficiency and decreased inducible fibrinolysis].
    Schoch U; Zanetti E; von Felten A
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1807-10. PubMed ID: 2962279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Termination of pregnancy in the 2nd trimester using intra-amniotic administration of prostaglandins].
    Krofta L; Calda P; Zizka Z; Parízek A; Hrusková H; Kapras J
    Ceska Gynekol; 1998 Oct; 63(5):414-7. PubMed ID: 9818502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombin III deficiency and pregnancy. Apropos of a case].
    Tissot H; Vergnes MC; Serville F; Dallay D; Gonnet JM; Dubecq JP
    Rev Fr Gynecol Obstet; 1990; 85(7-9):473-7. PubMed ID: 2237157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin.
    Hellgren M; Tengborn L; Abildgaard U
    Gynecol Obstet Invest; 1982; 14(2):127-41. PubMed ID: 7117919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of antithrombin III concentrates to correct antithrombin III deficiency during vascular surgery.
    Jackson MR; Olsen SB; Gomez ER; Alving BM
    J Vasc Surg; 1995 Dec; 22(6):804-7. PubMed ID: 8523616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an optimal dose of low-molecular-weight heparin for thromboprophylaxis in pregnant women at risk of thrombosis using coagulation activation markers.
    Bombeli T; Raddatz Mueller P; Fehr J
    Haemostasis; 2001; 31(2):90-8. PubMed ID: 11684864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.